Jeil Pharm - Asset Resilience Ratio

Latest as of March 2026: 2.93%

Jeil Pharm (002620) has an Asset Resilience Ratio of 2.93% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jeil Pharm working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩25.77 Billion

≈ $17.46 Million USD Cash + Short-term Investments

Total Assets

₩878.26 Billion

≈ $595.18 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Jeil Pharm's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Jeil Pharm's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Jeil Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Jeil Pharm to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩25.77 Billion	2.93%
Total Liquid Assets	₩25.77 Billion	2.93%

Asset Resilience Insights

Limited Liquidity: Jeil Pharm maintains only 2.93% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jeil Pharm Industry Peers by Asset Resilience Ratio

Compare Jeil Pharm's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Jeil Pharm (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Jeil Pharm.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.64%	₩23.12 Billion ≈ $15.67 Million	₩876.66 Billion ≈ $594.10 Million	+0.83pp
2024-12-31	1.80%	₩16.06 Billion ≈ $10.89 Million	₩890.43 Billion ≈ $603.43 Million	-0.71pp
2023-12-31	2.51%	₩22.09 Billion ≈ $14.97 Million	₩880.00 Billion ≈ $596.36 Million	+0.36pp
2022-12-31	2.15%	₩18.64 Billion ≈ $12.63 Million	₩865.68 Billion ≈ $586.66 Million	+0.06pp
2021-12-31	2.09%	₩18.64 Billion ≈ $12.63 Million	₩892.42 Billion ≈ $604.78 Million	+0.99pp
2020-12-31	1.10%	₩9.78 Billion ≈ $6.63 Million	₩887.40 Billion ≈ $601.37 Million	+0.05pp
2019-12-31	1.05%	₩8.88 Billion ≈ $6.01 Million	₩846.47 Billion ≈ $573.64 Million	+0.65pp
2018-12-31	0.40%	₩3.69 Billion ≈ $2.50 Million	₩920.09 Billion ≈ $623.53 Million	-2.05pp
2017-12-31	2.45%	₩4.84 Billion ≈ $3.28 Million	₩197.59 Billion ≈ $133.90 Million	+1.81pp
2016-12-31	0.64%	₩3.15 Billion ≈ $2.14 Million	₩491.98 Billion ≈ $333.41 Million	-0.06pp
2015-12-31	0.70%	₩3.10 Billion ≈ $2.10 Million	₩445.17 Billion ≈ $301.68 Million	-1.86pp
2012-12-31	2.56%	₩9.99 Billion ≈ $6.77 Million	₩390.77 Billion ≈ $264.82 Million	-5.11pp
2011-12-31	7.67%	₩29.44 Billion ≈ $19.95 Million	₩384.13 Billion ≈ $260.32 Million	--

pp = percentage points

About Jeil Pharm

KO:002620 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$79.90 Million

₩117.90 Billion KRW

Market Cap Rank

#20166 Global

#1075 in Korea

Share Price

₩7680.00

Change (1 day)

+0.00%

52-Week Range

₩6290.00 - ₩9280.00

All Time High

₩92178.44